How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey

Yoshihito Yokoyama, Kiyoshi Ito, Kiyoshi Takamatsu, Kazuhiro Takehara, Toru Nakanishi, Kenichi Harano, Hidemichi Watari, Nobuyuki Susumu, Daisuke Aoki, Toshiaki Saito

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: This survey sought to determine Japanese gynecologists’ attitudes concerning administering hormone replacement therapy (HRT) for patients after surgery for endometrial cancer (EC). Methods: Eight hundred and eighty-eight members of the Japanese Gynecologic Oncology Group (JGOG) were asked to respond to an anonymous questionnaire on the JGOG website. The survey asked whether or not HRT was to be administered when surgery was performed (including a hysterectomy and bilateral oophorectomy) to treat EC before or after menopause. If HRT was not to be administered, respondents were asked the reason why. Respondents were presented with the same hypothetical patients that were featured in a previous survey in Germany, and differences in the mindsets of Japanese and German physicians were compared. Results: Responses from 363 individuals (response rate 40.9 %) were analyzed. Seventy-eight percent of physicians considered HRT for patients undergoing surgery before menopause. The most prevalent reason of refusal to prescribe HRT was the risk of EC recurrence. Forty-eight percent of physicians considered HRT for patients undergoing surgery after menopause. The most prevalent reasons of refusal of HRT were its limited benefit and the availability of alternative therapies. Sixty-five percent of Japanese physicians responded that they would administer HRT to patients with low risk of recurrence vs. 46 % of physicians in Germany (P 

Original languageEnglish
Pages (from-to)997-1004
Number of pages8
JournalInternational Journal of Clinical Oncology
Volume20
Issue number5
DOIs
Publication statusPublished - 2015 Oct 3

Fingerprint

Hormone Replacement Therapy
Endometrial Neoplasms
Survivors
Physicians
Menopause
Germany
Recurrence
Surveys and Questionnaires
Ovariectomy
Complementary Therapies
Hysterectomy

Keywords

  • Anonymous questionnaire
  • Endometrial cancer
  • Hormone replacement therapy
  • Japanese gynecologists attitude

ASJC Scopus subject areas

  • Oncology
  • Surgery
  • Hematology

Cite this

How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey. / Yokoyama, Yoshihito; Ito, Kiyoshi; Takamatsu, Kiyoshi; Takehara, Kazuhiro; Nakanishi, Toru; Harano, Kenichi; Watari, Hidemichi; Susumu, Nobuyuki; Aoki, Daisuke; Saito, Toshiaki.

In: International Journal of Clinical Oncology, Vol. 20, No. 5, 03.10.2015, p. 997-1004.

Research output: Contribution to journalArticle

Yokoyama, Yoshihito ; Ito, Kiyoshi ; Takamatsu, Kiyoshi ; Takehara, Kazuhiro ; Nakanishi, Toru ; Harano, Kenichi ; Watari, Hidemichi ; Susumu, Nobuyuki ; Aoki, Daisuke ; Saito, Toshiaki. / How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey. In: International Journal of Clinical Oncology. 2015 ; Vol. 20, No. 5. pp. 997-1004.
@article{d700e2ff72a14c4eaaec136a3abd5ff7,
title = "How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey",
abstract = "Background: This survey sought to determine Japanese gynecologists’ attitudes concerning administering hormone replacement therapy (HRT) for patients after surgery for endometrial cancer (EC). Methods: Eight hundred and eighty-eight members of the Japanese Gynecologic Oncology Group (JGOG) were asked to respond to an anonymous questionnaire on the JGOG website. The survey asked whether or not HRT was to be administered when surgery was performed (including a hysterectomy and bilateral oophorectomy) to treat EC before or after menopause. If HRT was not to be administered, respondents were asked the reason why. Respondents were presented with the same hypothetical patients that were featured in a previous survey in Germany, and differences in the mindsets of Japanese and German physicians were compared. Results: Responses from 363 individuals (response rate 40.9 {\%}) were analyzed. Seventy-eight percent of physicians considered HRT for patients undergoing surgery before menopause. The most prevalent reason of refusal to prescribe HRT was the risk of EC recurrence. Forty-eight percent of physicians considered HRT for patients undergoing surgery after menopause. The most prevalent reasons of refusal of HRT were its limited benefit and the availability of alternative therapies. Sixty-five percent of Japanese physicians responded that they would administer HRT to patients with low risk of recurrence vs. 46 {\%} of physicians in Germany (P ",
keywords = "Anonymous questionnaire, Endometrial cancer, Hormone replacement therapy, Japanese gynecologists attitude",
author = "Yoshihito Yokoyama and Kiyoshi Ito and Kiyoshi Takamatsu and Kazuhiro Takehara and Toru Nakanishi and Kenichi Harano and Hidemichi Watari and Nobuyuki Susumu and Daisuke Aoki and Toshiaki Saito",
year = "2015",
month = "10",
day = "3",
doi = "10.1007/s10147-015-0808-5",
language = "English",
volume = "20",
pages = "997--1004",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",
number = "5",

}

TY - JOUR

T1 - How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey

AU - Yokoyama, Yoshihito

AU - Ito, Kiyoshi

AU - Takamatsu, Kiyoshi

AU - Takehara, Kazuhiro

AU - Nakanishi, Toru

AU - Harano, Kenichi

AU - Watari, Hidemichi

AU - Susumu, Nobuyuki

AU - Aoki, Daisuke

AU - Saito, Toshiaki

PY - 2015/10/3

Y1 - 2015/10/3

N2 - Background: This survey sought to determine Japanese gynecologists’ attitudes concerning administering hormone replacement therapy (HRT) for patients after surgery for endometrial cancer (EC). Methods: Eight hundred and eighty-eight members of the Japanese Gynecologic Oncology Group (JGOG) were asked to respond to an anonymous questionnaire on the JGOG website. The survey asked whether or not HRT was to be administered when surgery was performed (including a hysterectomy and bilateral oophorectomy) to treat EC before or after menopause. If HRT was not to be administered, respondents were asked the reason why. Respondents were presented with the same hypothetical patients that were featured in a previous survey in Germany, and differences in the mindsets of Japanese and German physicians were compared. Results: Responses from 363 individuals (response rate 40.9 %) were analyzed. Seventy-eight percent of physicians considered HRT for patients undergoing surgery before menopause. The most prevalent reason of refusal to prescribe HRT was the risk of EC recurrence. Forty-eight percent of physicians considered HRT for patients undergoing surgery after menopause. The most prevalent reasons of refusal of HRT were its limited benefit and the availability of alternative therapies. Sixty-five percent of Japanese physicians responded that they would administer HRT to patients with low risk of recurrence vs. 46 % of physicians in Germany (P 

AB - Background: This survey sought to determine Japanese gynecologists’ attitudes concerning administering hormone replacement therapy (HRT) for patients after surgery for endometrial cancer (EC). Methods: Eight hundred and eighty-eight members of the Japanese Gynecologic Oncology Group (JGOG) were asked to respond to an anonymous questionnaire on the JGOG website. The survey asked whether or not HRT was to be administered when surgery was performed (including a hysterectomy and bilateral oophorectomy) to treat EC before or after menopause. If HRT was not to be administered, respondents were asked the reason why. Respondents were presented with the same hypothetical patients that were featured in a previous survey in Germany, and differences in the mindsets of Japanese and German physicians were compared. Results: Responses from 363 individuals (response rate 40.9 %) were analyzed. Seventy-eight percent of physicians considered HRT for patients undergoing surgery before menopause. The most prevalent reason of refusal to prescribe HRT was the risk of EC recurrence. Forty-eight percent of physicians considered HRT for patients undergoing surgery after menopause. The most prevalent reasons of refusal of HRT were its limited benefit and the availability of alternative therapies. Sixty-five percent of Japanese physicians responded that they would administer HRT to patients with low risk of recurrence vs. 46 % of physicians in Germany (P 

KW - Anonymous questionnaire

KW - Endometrial cancer

KW - Hormone replacement therapy

KW - Japanese gynecologists attitude

UR - http://www.scopus.com/inward/record.url?scp=84942982400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942982400&partnerID=8YFLogxK

U2 - 10.1007/s10147-015-0808-5

DO - 10.1007/s10147-015-0808-5

M3 - Article

C2 - 25744579

AN - SCOPUS:84942982400

VL - 20

SP - 997

EP - 1004

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

IS - 5

ER -